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Background: Recently, it has become evident that RNA editing-related changes are important in the modulation 
of neuronal information processing. Alternatively edited transcripts, when meagerly present, are hard to detect. 
Significant functional consequences may result, however, from small differences in editing efficiency. Moreover, 
it is difficult to evaluate the ratio of edited transcripts. The glycine receptor alpha3 subunit (GlyR alpha3) is ex-
pressed in the spinal cord, and transcripts of GlyR alpha3 are susceptible to RNA editing. The physiological role 
of this editing is still unclear. To analyze changes in RNA editing in various animal models, we need reliable and 
practical ways to detect and quantitate GlyR alpha3 RNA editing. 
Results: We identified and assessed different ways of detecting edited RNA transcripts, including direct se-
quencing, denaturing high performance chromatography (DHPLC), allele-specific real-time PCR with TaqMan 
probes, and PCR with allele-specific primers. Using PCR with allele-specific primers on standard PCR products 
for edited and nonedited GlyR alpha3, we were able to detect as little as a 0.5% incidence of edited transcripts. 
We were able to detect a 5% incidence of RNA editing using direct sequencing and 2% using DHPLC. We could 
accurately determine the ratio of edited to non-edited RNA using DHPLC, direct sequencing, and allele-specific 
real-time PCR with TaqMan probes. 
Conclusion: We demonstrated exact and sensitive methods of detecting RNA editing. In prepared samples, we 
showed means of quantitating the incidence of editing of a particular site. The demonstrated methodologies 
should be very useful when extended to the evaluation of other types of RNA editing and single base mutations. 
Key words: RNA editing, glycine alpha 3 subunit, DHPLC, direct sequencing, allele-specific primer, allele-specific TaqMan 
PCR method 
1. Introduction 
RNA editing is broadly defined as any RNA 
processing event (excluding RNA splicing) that gen-
erates an RNA message with a nucleotide sequence 
that differs from corresponding genomic DNA. Re-
cently, it has become evident that RNA editing plays 
an important role in the modulation of neuronal in-
formation processing, and that small differences in 
editing efficiency can have significant functional con-
sequences. Mammalian RNA editing generally occurs 
by either cytosine-to-uracil (C-to-U) or adeno-
sine-to-inosine (A-to-I) deamination. Good examples 
of C-to-U editing include conversions, mediated by a 
citidine deaminase in conjunction with additional cel-
lular machinery, within apolipoprotein B RNA [1] and 
neurofibromin [2] . Elsewhere, involving alteration of 
the mRNA of glutamate and serotonin receptors, 
A-to-I editing of several neuronal genes has been iden-
tified. RNA editing similarly affects potassium chan-
nels. Functional consequences include effects on cal-
cium ion permeability (GluR6; [3]), on control of G 
protein activation (5HT2c; [4]), and on modulation of 
channel inactivation (hKv1.1; [5]). A-to-I editing is 
caused by the ADAR (adenosine deaminases that act 
on RNA) family of enzymes [6]. The occurrence of 
inosine in poly(A)+ mRNA has been estimated at one 
base in 17,000 in rat brain and one in 33,000 in rat 
heart [7]. Very few edited transcripts have been iden-
tified [6], and it is likely that many edited transcripts 
await discovery. If inosine occupies a guanosine site Int. J. Biol. Sci. 2008, 4 
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during the translation process, its presence can alter 
the encoded protein [8]. Consequently, in neurosci-
e n c e ,  i t  i s  v e r y  i m p o r t a n t  t o  f i n d  w a y s  o f  d e t e c t i n g  
these meagerly existing edited transcripts. 
  The glycine receptor alpha3 subunit (GlyR al-
pha3) is expressed in the spinal cord where it physio-
logically plays a pivotal role in pros-
taglandin-mediated inflammatory pain transmission 
in the spinal cord dorsal horn. GlyR alpha3 transcripts 
are susceptible to RNA editing. These edited isoforms 
cause physiological changes. GlyR alpha3P185L, result-
ing from cytidine 554 deamination, endows neurons 
with high glycine sensitivity and promotes sustained 
chloride conductance associated with tonic inhibition. 
[9] The physiological role of this editing is still un-
clear. To analyze changes in RNA editing in various 
animal models, we need reliable and practical ways of 
detecting and quantitating GlyR alpha3 RNA editing. 
  More easily detected than edited RNA, single 
nucleotide polymorphisms (SNPs) are commonly 
identified by various methods. Because editing creates 
such subtle changes in the sequence, it is as difficult to 
detect edited transcripts as it is to detect micro-exons. 
It has been possible, however, to greatly improve as-
say sensitivity by using PCR products as a template 
and sequencing with thermostable polymerases 
[10,11,12]. Very small amounts of mRNA can now be 
assayed by amplifying the template with RT-PCR, but 
few studies have yet presented detailed reports of the 
factors that contribute to the accuracy of the assay 
[13,14,15,16]. We tried four different methods of de-
tecting and determining the ratio of ed-
ited-to-non-edited transcripts: DHPLC; direct se-
quence; and allele-specific real-time PCR with 
TaqMan probe as a qualitative and sensitive methods: 
and PCR using allele-specific primers as a sensitive 
method. We evaluated the four methods in detail. 
2. Material and methods 
Total clone making 
RNA was isolated from rat spinal cord and 
cDNA was obtained by reverse transcription using 
oligo-dT. The full length cDNA encoding rat GlyR 
alpha3 subunit was amplified using oligonucleotides 
5’-AACATGCATAATGCAACTCG-3’ and 
5’-CCATCCAAATGTCAATTGC-3’ and subcloned 
into TA cloning vector pCR2.1. (Invitrogen, Tokyo, 
Japan). The site-directed mutation for GlyR alpha3 
(P185L) was performed by QuikChange mutagenesis 
kit (Stratagene Tokyo, Japan). We use TA Cloning kit 
(Invitrogen, Tokyo, Japan) for ligation and TOPO 10 
(Invitrogen, Tokyo, Japan) for transformation. After 
purification of plasmids, we carried out direct se-
quencing and confirmed that the samples contained 
completely full-length GlyR alpha3 wild and mutant 
clones. 
Preparation of standard samples 
We performed quantitative RT–PCR of GlyR al-
pha3 edited and nonedited full length samples, ac-
cording to the manufacturer’s protocol, with an ABI 
PRISM 7900HT (Applied Biosystems, Foster City, CA) 
using TaqMan probes supplied by Applied Biosys-
tems. All reactions were run in duplicate. We per-
formed the quantitation of both edited and nonedited 
samples using standard curve methods. Standard 
samples were prepared by controlling the concentra-
tion of these two samples at same detection cycles. 
Standard PCR products 
We made the standard PCR products (fragment 
467 bp) for edited and nonedited GlyR alpha3 with 
optimase polymerase (high fidelity polymerase) using 
oligonucleotides 
F>5’AATGTTCTTTATTCAATAAGGCTGA3’ and 
R>5’ACATAGGACACCTTTGGTAAAGAA3’ which 
flank the editing site (Fig. 1). A 467 bp fragment was 
amplified in a reaction using, as recommended by the 
manufacturer, 1.25 units of polymerase, 0.5 μM of each 
primer, and a reaction buffer with Mg2+ along with 
approximately 1 ng Plasmid DNA template, 200 μM of 
each dNTP and distilled water to a final volume of 50 
μl. Cycling conditions were 1 cycle at 95°C for 5 min 
followed by 25 cycles of 95°C for 45 s, 55°C for 45s, 
72°C for 1.5 min, and 72°C for 7 min. 
 
 
Figure 1. The primers and probe design for making standard 
PCR products and for quantitation of standard PCR products. In 
the sequence C/T denotes the editing site. 
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Figure 2. PCR using allele-specific primers. A) ASP forward primer design. Two bases (one is a site of editing) were mismatched. 
B) PCR using ASPs could detect GlyR alpha3 editing incidences as low as 0.5%. While the 273 bp band for Lane 1 is clearly not 
apparent, high-intensity 273 bp bands are evident for Lanes 2–4; however, this technique cannot be considered quantitative. A false 
positive signal in the band for ASP–PCR was also noted. C) The band intensity was almost same for 0.5%, 99.5%, and 100% sam-
ples. This method was considered to be unsuitable for quantitation. D) The template concentration of edited plasmid was considered 
to be important for this assay condition. A minimum presence of original edited plasmid in the amount of between 0.001 ng and 
0.0001 ng is regarded as a lower limit for practical measurement. ASP, allele-specific primers. Int. J. Biol. Sci. 2008, 4 
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PCR using allele-specific primers (ASP) 
So we could ascertain the detection limit, in 
standard dilutions, the PCR products of edited and 
nonedited plamids were mixed in differing pro-
portions. When we examined the results of these tri-
als, it was apparent that it was better for the edited site 
to be situated in the forward primer. If sited in the 
reverse primer, the 3’ end would be G and this would 
greatly increase the likelihood of nonspecific amplifi-
cation. After designing a pair of allele-specific primers 
(Fig. 1 and 2A), F>5’AAGGACTCACTTTGTTT3’ and 
R>GGGATCCAGAACTCT3’, we carried out PCR us-
ing allele-specific primers with rTth DNA Polymerase 
XL (Applied Biosystems, Tokyo, Japan). PCR condi-
tions were 25 cycles of 2 min at 94°C, 15 s at 94°C and 
30 s at 60°C, another 40 cycles of 15 s at 94°C, and 30 s 
at 57°C. 
  After PCR using allele-specific primers, the PCR 
products were electrophoresed on 1% agarose gel at 
100 V/cm in 1×TAE. Following electrophoresis, gels 
were incubated in SYBER Green solution for 1 min. 
Gels were scanned directly at 488 mm using a Fluor-
oImager (Molecular Dynamics, Sunnyvale, CA). SYBR 
Green fluorescence was captured using a 530DF30 
filter with the photomultiplier tube voltage was set at 
700 V. 
 Scans were analyzed using ImageQuant software 
(Amersham Bioscience, Tokyo, Japan). Band intensi-
ties were compared using the average value of the in-
tegrated pixel intensity for a two-pixel line drawn 
through the middle of each lane. We analyzed the 
band intensity by calculating when band intensity for 
edited plasmids would be 100% ( The value of the 
each band intensity(%) = the actual value of each 
sample intensity / the actual value of 100% edited 
plasmid’s band intensity *100) . When we analyzed 
the detection limit, the band intensity of the 0.1 ng 
template was estimated to have a value of 100. Results 
for the different samples were indexed on this scale of 
100. 
DHPLC analysis 
Denaturing HPLC was performed using a WAVE 
DNA fragment analysis system with a DNASep col-
umn (Transgenomic, Tokyo, Japan). To generate het-
eroduplex molecules, PCR products were subjected to 
denaturation for 4 min at 94°C followed by a gradual 
reannealing for 45 min in the thermal cycler. Aliquots 
of 5 μl of reannealed PCR products were loaded in a 
column. The gradient was prepared by mixing TEAA 
buffer A (0.1 M triethylammonium acetate). Primer 
extension products were eluted using a linear gradient 
from 18%B to 38%B at a flow rate of 0.9 ml/min for 7 
min. Column temperature was set at 57.9°C. The 
eluted products were monitored at 260 nm using the 
UV detector. After each elution, the column was 
washed and equilibrated with the gradient of 90%B 
and 18%B, each for 1 min. Peaks were identified using 
standard PCR products as described above. RNA ed-
iting efficiency was calculated by comparing the peak 
heights after peak fitting with Gaussian curves corre-
sponding to edited and non-edited extension prod-
ucts. The RNA editing efficiency of each sample was 
analyzed in duplicate. 
Direct sequencing 
Standard PCR products were purified using col-
umn purification on glass fibers (Qiagen ,Tokyo, Ja-
pan). We mixed the two purified standard PCR prod-
ucts at various ratios. These mixed samples were se-
quenced on an ABI PRISM3100 Genetic Analyzer us-
ing BigDye terminator v1.1 sequencing kits (both Ap-
plied Biosystems, Tokyo, Japan). The raw relative 
peak amplitude data for each sample was analyzed. 
Allele-specific real time PCR method 
We designed a primer and probe for quantitating 
GlyR alpha 3 gene expression. (GlyRalpha3 forward 
primer, GAGCGGCAAATGGGCTACTA; GlyR al-
pha3 reverse primer, ACCCAGGACAGAATGACAA 
TCAG; GlyR alpha3-MGB probe, 
ATCCAGATGTACATTCCCAG.) 
Each standard real-time PCR reaction mixture 
contained a 5 μl sample of edited or nonedited plas-
mids, 1.5 μl (300 nM) of 10 pmol/μl forward primer, 
4.5 μl (900 nM) of 10 pmol/μl reverse primer, 1.25 μl 
(250 nM) of 10 pmol/μl TaqMan MGB probe, 25 μl of 
TaqMan® Universal PCR Master Mix. The total reac-
tion volume was 50 μl. The amplification program 
consisted of at 50°C for 2 min and 95°C for 8 min fol-
lowed by 40 cycles of 15 s of denaturation 95°C, 1 min 
annealing at 55°C, and 1 min extension at 62°C. Based 
on these quantitaion data, we produced standard 
plasmids of same concentration. 
  To derive the editing ratio of the samples, we 
designed two TaqMan® MGB probes for quantitation 
using FAM and VIC, whose sequences matched edited 
and nonedited sites (GlyR alpha3 nonediting probe: 
TCACTTTGCCTCAATT and GlyR alpha3 editing 
probe: ACTCACTTTGCTTCAAT)) and a pair of 
flanking primers (GlyR alpha3 1017F, 
AGCACCAGTACAAGTGGCTGAA; and 1092R, 
GCAGTATCGCAAATCTTTTTCTTCT). Next, we 
mixed samples with edited and nonedited plasmids 
included at various known ratios. Each allele-specific Int. J. Biol. Sci. 2008, 4 
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real-time PCR reaction mixture contained a 5 μl mixed 
plasmid sample, 4.5 μl (900 nM) of 10 pmol/μl for-
ward primer, 4.5 μl (900 nM) of 10 pmol/μl reverse 
primer, 1.0 μl (200 nM) of 10 pmol/μl TaqMan editing 
probe, 1.0 μl (200 nM) of 10 pmol/μl TaqMan 
nonediting probe, 25 μl of TaqMan Universal PCR 
Master Mix. Total reaction volume was 50 μl. The am-
plification program consisted of 2 min at 50°C and 10 
min at 95°C followed by 40 cycles of 15 s denaturation 
at 95°C, and annealing for 1 min at 60°C. The quanti-
ties of each allele were determined using the compara-
tive Ct method with these two probes and analysis on 
a real time PCR system (Applied Biosystems 7300; 
Tokyo, Japan). Regression analysis was performed on 
the results for samples of each ratio. 
Statistical analysis 
The correlation coefficient was obtained using 
simple regression analysis (Microsoft Excel; Redmond, 
WA). 
3. Results 
Our goal was to find and compare inexpensive 
assays that gave accurate quantitative or sensitive re-
sults. We found one method that was solely sensitive 
and three that were sensitive and quantitative. 
Detection of RNA editing using allele-specific 
primers  
Using allele-specific primers, we were able to 
detect a 0.5% incidence of editing sites. Figure 2 shows 
results using allele-specific primer (ASP) assays with 
control reactions. When the incidence of edited tran-
scripts was more than 0.5%, 267 bp bands were clearly 
visible when the samples were analyzed (Fig. 2B). In-
tensity in these bands was not the same as for 
non-edited plasmid samples and we concluded that 
this method, while not quantitative, did enable detec-
tion and that the detection limit was between 0.001 ng 
and 0.0001 ng. (Fig. 2C, 2D) 
Detection and quantitation of RNA editing by direct 
sequencing 
To perform determine the accuracy of this assay, 
we mixed edited and non-edited GlyR alpha 3 stan-
dard PCR products (Fig. 3). The two kinds of PCR 
product, otherwise identical, contained either a C or a 
T at position 554. From the raw direct-sequencing 
data, peak intensities of fluorescence for each of the 
variously edited and nonedited samples were re-
corded. Fitting the data with a linear R2 value of 0.986, 
these peaks accurately reflected the ratios in the plas-
mid mixes. Detection was only sensitive down to an 
incidence of 5% of the total, lower incidences of edit-
ing were not detected (Fig. 3). 
 
 
Figure 3. Typical chromatogram of direct sequencing and quantitation of known mixed-template assay results. The known ratio of 
edited-to-nonedited plasmids is plotted against the values measured in the chromatogram assay. The least-squares fit of the actual 
data is defined by the equation y = 1.11x + 0.72, p = < 0.001.  Int. J. Biol. Sci. 2008, 4 
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Detection and quantitation of RNA editing using 
DHPLC analysis 
DHPLC (denaturing high performance liquid 
chromatography) is commonly used for detecting 
mutations through screening of PCR products for het-
erogeneity (Fig. 4). While edited products could be 
detected even when they made up as little as 2% of the 
total transcripts (Fig. 4 above), at levels below 10%, it 
was difficult to analyze DHPLC data to accurately de-
termine actual quantities. We also tested mixtures that 
contained different percentages of nonedited and ed-
ited PCR products and Figure 4 shows the results for 
this DHPLC. For samples containing 10% to 90% mu-
tant transcripts, these results accurately reflect the 
plasmid-mix ratios, fitting the data with a linear R2 
value of 0.972. 
Implementation of al-
lele-specific real-time 
PCR method with 
TaqMan probe 
We confirmed that 
the amplification effi-
ciencies of primers used 
for edited and nonedited samples were approximately 
equal (data not shown). We tested two MGB probes at 
various ratios of control plasmid and confirmed that 
t h e y  w e r e  s p e c i f i c  t o  e a c h  c l o n e  o f  G l y  a l p h a 3  ( F i g .  
5B). In other words, edited probes were highly specific 
only for edited transcripts and the nonedited probed 
were highly specific only for nonedited transcripts. 
Then, we analyzed various ratios of edited and 
nonedited products using these primers and probes. 
We were able to determine the editing ratios at y = 
25.237 e-0.9337X (R2 = 0.9919; y, measured value; x, actual 
value) (Fig. 5C). 
 
 
Figure 4. DHPLC analysis. 
Each chromatogram shows 
results of DHPLC analysis 
for PCR products amplified 
using mixed templates of 
different ratios of editing 
(0%–5%, 95%–100%). Al-
though two distinguishable 
heteroduplex and homodu-
plex peaks were not apparent, 
a small peak (heteroduplex) 
next to a large peak was seen 
in mixes in which 2% or 
more of plasmids were ed-
ited. Quantitation of known 
template assay results. The 
least-squares fit of the actual 
data is defined by the equa-
tion y = 0.718x + 13.1, p = < 
0.001. Int. J. Biol. Sci. 2008, 4 
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Figure 5. (A) Two TaqMan
® MGB probes using FAM
TM 
and VIC
®, whose sequences matched edited or nonedited 
sites, and a pair of flanking primers was designed to 
increase the precision of allele-specific quantitation. In 
the sequence, C/T denotes the edited site. (B) The quan-
tities of each allele were evaluated from ∆Ct results from 
a real-time PCR system (TaqMan ABI 7300). (C) Quan-
titation using allele-specific real time PCR methods. 
Assuming that ∆Ct was equal to zero when the editing 
ratio was 50%, logistic regression analysis of the inci-
dence of editing in differently mixed samples was per-
formed. Correlation between measured values and cor-
rected ∆Ct is shown. The actual data is defined by the 
equation y = 25.237e
 -0.9337x, p = < 0.001 (y: measured 
value, x: actual value). 
 Int. J. Biol. Sci. 2008, 4 
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4. Discussion 
The ability to measure subtle differences in edit-
ing efficiency is becoming increasingly important, 
particularly for clinical studies. For example, minute 
reductions in editing efficiency have been associated 
with clinical depression, suicide, certain forms of epi-
lepsy, and schizophrenia [4,17,18,19,20,]. The proper-
ties of alpha amino-3-hydroxy-5-methyl-4-isoxazole-
prpionate (AMPA) receptor are generated 
post-transcriptionally by RNA editing at the Q/R site, 
where deficient RNA editing of GluR2 is associated 
with neuronal death in amytropic lateral sclerosis 
[21,22]. Recently, a number computational methods 
for detecting A-to-I RNA editing sites have been pro-
posed [23], and algorithmic approaches for identifying 
RNA editing sites have been discussed [24]. The 
methods of testing that we have demonstrated here 
are useful, at the study planning stage, for establishing 
the means of detecting and quantifying editing ratios 
within a short time. 
  We found that the best way of detecting of al-
ready known RNA editing was PCR with al-
lele-specific primer pairs. If good primer pairs are cre-
ated, this method is simple and inexpensive; however, 
because the polymerase amplification is susceptible to 
approximately 1% error [25], it is not always accurate. 
The relevant analytical efficacy of this low-cost option 
must be carefully considered. Our PCR results with 
ASPs were excellent and useful for identifying if edit-
ing had occurred. 
  If it is not possible to properly design ASPs, 
DHPLC may be feasible. The DHPLC method has 
been used successfully for detecting point mutations 
at very low (0.5%–5.0%) percentages of heterogeneity 
[26, 27]. DHPLC may be useful because it can inex-
pensively provide analysis of known editing. Using 
direct sequencing, assay detection of editing inci-
dences is 20% in general, and in our analysis we 
managed to detect, and measure accurately, inci-
dences as low as 5%. Unfortunately, direct sequencing 
incurs high costs. Thus, direct sequencing is too ex-
pensive to use from the beginning. Another option, if 
the editing site is already known, is the use of al-
lele-specific TaqMan probes. If the primer and probe 
are designed especially for detection, this method can 
provide detectability down to 2% (data not shown). 
But the primer–probe pair which we designed for de-
tection was not at all useful for quantitation. Further-
more, there is no special cost benefit in using al-
lele-specific TaqMan probes. 
 For quantitating already known RNA editing ra-
tios, direct-sequencing and DHPLC used in combina-
tion with allele-specific TaqMan probes were useful. 
Compared against the edited/nonedited ratios of 
known standard samples, results for DHPLC (R2 = 
0.973), from allele-specific TaqMan probes (R2 = 0.992), 
a n d  f r o m  d i r e c t  s e q u e n c i n g  ( R 2 = 0.987) correlated 
well. Allele-specific TaqMan probes yielded the clos-
est correlation because they were designed and used 
in conditions that favored quantitation of the inci-
dence of editing. Conversely, such probes are not 
suitable for blind detection. Even so, once the primers 
and probe are designed and evaluated, this method is 
both accurate and easy to perform. Consequently, it is 
very useful for evaluating samples in which RNA ed-
iting is known to have occurred. Meanwhile, DHPLC 
is inexpensive and has good detection sensitivity 
down to 2%. So DHPLC would appear to be an excel-
lent means both of RNA editing detection and quanti-
tation. Our results using DHPLC, however, did mani-
fest a shortcoming. In the protocol we used, we were 
unable to determine four peaks, which should be de-
tectable in ideal conditions. We were unable to ascer-
tain which peaks were edited or non-edited. For con-
firmation, supplementary procedures involving stan-
dard samples were necessary. Of the methods we used 
for detecting and quantitating samples in which par-
tial editing at the site of GlyR alpha3 was present, we 
conclude that ASP was best for detection and that 
T a q M a n  p r o b e s  o r  d i r e c t  s e q u e n c i n g  g a v e  s u p e r i o r  
quantitation results. 
  Recently, computational methods for detecting 
A-to-I RNA editing sites have been introduced [23]. 
Such analysis has revealed thousands of editing sites 
within the genomic reiteration, and has also brought 
to light some novel genetic recoding sites. If computa-
tional methods are used for prediction, preliminary 
testing of predicted gene clones could be simply and 
inexpensively carried out using ASP. DHPLC could 
then be used to review non-conforming ASP results. 
Furthermore, when it is known that editing has oc-
curred in a real sample, direct sequencing can be used 
to confirm the suspected editing site. When priority is 
given to quantitation, TaqMan probes or direct se-
quencing should be used. 
  For detecting and quantitating a specific type of 
editing, ASP and DHPLC are suitable for initial detec-
tion, followed by quantitation using direct sequencing 
or allele-specific TaqMan probes. To screen for un-
known editing, from the options tested, DHPLC or 
direct sequencing should be considered. 
It is, of course, essential to carry out validation 
using clones of each sample. We suppose that for any 
type of unknown RNA editing, the techniques re-
ported here can enable identification and quantitation 
of the SNP. It is important, however, to use the 
method that is most appropriate for the specific pur-Int. J. Biol. Sci. 2008, 4 
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pose and circumstance. 
In conclusion, we evaluated four different ways 
of detecting and quantitating the incidence of RNA 
editing. These techniques and our findings should be 
of interest to anyone carrying out research on other 
RNA editing sites, especially single-base editing pat-
terns. The methodologies presented here are likely to 
be beneficial for current and future studies aimed at 
understanding the relationship between the editing 
incidence of a target gene and the effectiveness of cor-
responding physiological or pharmacological pheno-
types. 
Acknowledgements 
This work was supported by a Grant-in-Aid (No. 
18791077) from the Ministry of Education, Culture, 
Sports, Science and Technology, Japan. The author 
would also like to thank Dr. Ichiro Uchida for provid-
ing the GlyR alpha3 clone and for detailed advice 
concerning the experimental design and Dr. Satoshi 
Hagihira for advice about statistical analysis. 
Conflict of interests 
The authors declare that they have no conflict of 
interest. 
References 
1.  Powell LM. A novel form of tissue-specific RNA processing 
produces apolipoprotein-B48 in intestine. Cell. 1987;50: 831–840. 
2.   Skuse GR, Cappione AJ, Sowden M, Metheny LJ, Smith HC. The 
neurofibromatosis type 1 messenger RNA undergoes 
base-modification RNA editing. Nucleic Acids Res. 1996;24: 
478–485. 
3.   Kohler M, Burnashev N, Sakmann B, Seeburg PH. Determinants 
of Ca2+ permeability in both TM1 and TM2 of high affinity 
kainite receptor channels: diversity by RNA editing. Neuron. 
1993;10: 491–500. 
4.   Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss 
C, Gurevich I. Altered editing of serotonin2C receptor 
pre-mRNA in the prefrontal cortex of depressed suicide victims. 
Neuron. 2002; 34: 349–356. 
5.   Bhalla T, Rosenthal JJ, Holmgren M, Reenan R: Control of hu-
man potassium channel inactivation by editing of a small mRNA 
hairpin. Nat Struct Mol Biol. 2004; 11:950–956. 
6.   Keegan LP, Gallo A, O’Connell MA. The many roles of an RNA 
editor. Nat Rev Genet. 2001; 2: 869–878. 
7.   Paul M, Bass BL. Inosine exists in mRNA at tissue-specific levels 
and is most abundant in brain mRNA. EMBO J. 1998;17: 
1120–1127. 
8.   Basilio C, Wahba AJ, Lengyel P, Speyer JF, Ochoa S. Synthetic 
polynucleotides and the amino acid code. Proc Natl Acad Sci U S 
A. 1962; 48: 613–616. 
9.  Meier JC, Henneberger C, Melnick I, Racca C, Harvey RJ, 
Heinemann U, Schmieden V, Grantyn R. RNA editing produces 
glycine receptor α3P185L, resulting in high agonist potency. Nat 
Neurosci. 2005; 8: 736–744 
10.  Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H. Regu-
lation of serotonin-2C receptor G-protein coupling by RNA ed-
iting. Nature. 1997; 387: 303–308. 
11.   Schiffer HH, Heinemann SF. A quantitative method to detect 
RNA editing events. Anal Biochem. 1999; 276: 257–260. 
12. Peeters NM, Hanson MR. Transcript abundance supersedes 
editing efficiency as a factor in developmental variation of 
chloroplast gene expression. RNA. 2002; 8: 497–511. 
13.   Gallo A, Thomson E, Brindle J, O’Connell MA, Keegan LP. Mi-
cro-processing events in mRNAs identified by DHPLC analysis. 
Nucleic Acids Res. 2002; 30: 3945–3953 
14.   Barbon A, Vallini I, Via LL, Marchina E, Barlati S. Glutamate 
receptor RNA editing: a molecular analysis of GluR2, GluR5 and 
GluR6 in human brain tissues and in NT2 cells following in vitro 
neural differentiation. Brain Res Mol Brain Res. 2003; 117: 
168–178 
15.   Chen YC, Kao SC, Chou HC, Lin WH, Wong FH, Chow WY. A 
real-time PCR method for the quantitative analysis of RNA ed-
iting at specific sites. Anal Biochem. 2008; 375: 46–52. 
16.    Chateigner-Boutin AL, Small I. A rapid high-throughput 
method for the detection and quantitation of RNA editing based 
on high-resolution melting of amplicons. Nucleic Acids Res. 
2007; 35(17): e114. 
17.   Sprengel R, Higuchi M, Monyer H, Seeburg PH. Glutamate 
receptor channels: A possible link between RNA editing in the 
brain and epilepsy. Adv Neurol. 1999; 79: 525–534. 
18.   Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ. 
RNA editing of the 5-HT (2C) receptor is reduced in schizo-
phrenia. Mol Psychiatry. 2001; 6: 373–379. 
19.   Vissel B, Royle GA, Christie BR, Schiffer HH, Ghetti A, Tritto T, 
Perez-Otano I, et al. The role of RNA editing of kainite receptors 
in synaptic plasticity and seizures. Neuron. 2001; 29: 217–227. 
20.   Schmauss C. Serotonin 2C receptors: Suicide, serotonin, and 
runaway RNA editing. Neuroscientist. 2003; 9: 237–242. 
21.   Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. 
Glutamate receptors: editing and death of motor neurons. Na-
ture. 2004; 427(6977): 801. 
22.   Kwak S, Kawahara Y. Deficient RNA editing of GluR2 and neu-
ronal death in amyotropic lateral sclerosis. J Mol Med. 2005; 
83:110–120. 
23.   Bundschuh R. Computational prediction of RNA editing sites. 
Bioinformatics. 2004; 20: 3214–3220. 
24.   Levanon EY, Eisenberg E. Algorithmic approaches for identifi-
cation of RNA editing sites. Brief Funct Genomic Proteomic. 
2006; 5: 43–45. 
25.   Goodman MF, Tippin B. The expanding polymerase universe. 
Nat Rev Mol Cell Biol. 2000; 1: 101–109. 
26.   van den Bosch BJ, de Coo RF, Scholte HR, Nijland JG, van Den 
Bogaard R, de Visser M, de Die-Smulders CE, Smeets HJ. Muta-
tion analysis of the entire mitochondrial genome using dena-
turing high performance liquid chromatography. Nucleic Acids 
Res. 2000; 28: E89. 
27.  Wolford JK, Blunt D, Ballecer C, Prochazka M. High-throughput 
SNP detection by using DNA pooling and denaturing high per-
formance liquid chromatography (DHPLC). Hum Genet. 2000; 
107: 483–487. 